The IRA is now law. What comes next?

AZBio President & CEO, Joan Koerber-Walker provides a brief overview of the provision of the Inflation Reduction act of 2022 (The IRA) from the patient and health innovation perspective and is then joined by health innovator and drug developer, Dr. Steven J. Potts, for a discussion of the potential unintended consequences of some provisions of The IRA relating to the future health innovation landscape.Continue reading

AZMN Launches Capital Campaign to Support New Virtual Cancer Caregivers Education Program

The  Virtual Cancer Caregivers Education Programs, VCCEP® address the challenges faced by cancer caregivers.  Delivered online, the VCCEP includes a ‘learning center’ that integrates 15 years of successful cancer caregiver workshops and training, including knowledge and perspectives from cancer patients, cancer caregivers and cancer care professionals.Continue reading

BIO Announces Appointment of Interim CEO

The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO. King’s appointment follows Dr. Michelle McMurry-Heath stepping down as President and CEO to serve as an Advisor to the Executive Committee of the BIO Board of Directors. The organization is searching for a full-time successor.Continue reading